NDC 69238-1596 Aminocaproic Acid
Solution Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 69238 - Amneal Pharmaceuticals Ny Llc
- 69238-1596 - Aminocaproic Acid
Product Characteristics
Product Packages
NDC Code 69238-1596-4
Package Description: 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (69238-1596-3)
NDC Code 69238-1596-8
Package Description: 236.5 mL in 1 BOTTLE, PLASTIC
Product Details
What is NDC 69238-1596?
What are the uses for Aminocaproic Acid?
What are Aminocaproic Acid Active Ingredients?
- AMINOCAPROIC ACID .25 g/mL - An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
Which are Aminocaproic Acid UNII Codes?
The UNII codes for the active ingredients in this product are:
- AMINOCAPROIC ACID (UNII: U6F3787206)
- AMINOCAPROIC ACID (UNII: U6F3787206) (Active Moiety)
Which are Aminocaproic Acid Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
- SORBITOL (UNII: 506T60A25R)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- WATER (UNII: 059QF0KO0R)
- RASPBERRY (UNII: 4N14V5R27W)
- GLYCERIN (UNII: PDC6A3C0OX)
What is the NDC to RxNorm Crosswalk for Aminocaproic Acid?
- RxCUI: 582299 - aminocaproic acid 0.25 GM/mL Oral Solution
- RxCUI: 582299 - 6-aminocaproic acid 250 MG/ML Oral Solution
- RxCUI: 582299 - 6-aminocaproic acid 0.25 GM per ML Oral Syrup
- RxCUI: 582299 - 6-aminocaproic acid 1.25 GM per 5 ML Oral Syrup
Which are the Pharmacologic Classes for Aminocaproic Acid?
* Please review the disclaimer below.
Patient Education
Aminocaproic Acid
Aminocaproic acid is used to control bleeding that occurs when blood clots are broken down too quickly. This type of bleeding may occur during or after heart or liver surgery; in people who have certain bleeding disorders; in people who have cancer of the prostate (a male reproductive gland), lung, stomach, or cervix (opening of the uterus); and in pregnant women experiencing placental abruption (placenta separates from the uterus before the baby is ready to be born). Aminocaproic acid is also used to control bleeding in the urinary tract (the organs in the body that produce and excrete urine) that may occur after prostate or kidney surgery or in people who have certain types of cancer. Aminocaproic acid should not be used to treat bleeding that is not caused by faster than normal clot breakdown, so your doctor may order tests to find the cause of your bleeding before you begin your treatment. Aminocaproic acid is in a class of medications called hemostatics. It works by slowing the breakdown of blood clots.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".